Evidence map›Paper›PMID 29858212›Full record

ArticleThe Journal of cell biology2018

Vav3-induced cytoskeletal dynamics contribute to heterotypic properties of endothelial barriers.

Georg Hilfenhaus, Dai Phuong Nguyen, Jonathan Freshman, Divya Prajapati, Feiyang Ma, Dana Song, Safiyyah Ziyad, Myriam Cuadrado, Matteo Pellegrini, Xosé R Bustelo and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Georg HilfenhausDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA.ORCID 0000-0001-8764-077X
Dai Phuong NguyenDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA.
Jonathan FreshmanDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA.
Divya PrajapatiDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA.
Feiyang MaDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA.
Dana SongDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA.
Safiyyah ZiyadDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA.
Myriam CuadradoCentro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer, and Centro de Investigación Biomédica en Red de Cáncer, Consejo Superior de Investigaciones Científicas, and University of Salamanca, Campus Unamuno, Salamanca, Spain.ORCID 0000-0001-9410-1205
Matteo PellegriniDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA.ORCID 0000-0001-9355-9564
Xosé R BusteloCentro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer, and Centro de Investigación Biomédica en Red de Cáncer, Consejo Superior de Investigaciones Científicas, and University of Salamanca, Campus Unamuno, Salamanca, Spain.ORCID 0000-0001-9398-6072
M Luisa Iruela-ArispeDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA arispe@mcdb.ucla.edu.ORCID 0000-0002-3050-4168
University of California, Los Angeles · USConsejo Superior de Investigaciones Científicas · ES

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
Vascular Growth and RegenerationR35HL140014 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI IRUELA-ARISPE, M. LUISA · 2018 to 2024
$6.6M
Underlying Mechanisms in AngiosarcomaR01CA197943 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI IRUELA-ARISPE, M. LUISA · 2015 to 2019
$1.8M
NCI NIH HHS P30 CA016042NCI NIH HHS R01 CA197943NHLBI NIH HHS R35 HL140014NIDDK NIH HHS P30 DK041301Worldwide Cancer Research 14-1248
6 · The paper itself

Abstract

Through multiple cell-cell and cell-matrix interactions, epithelial and endothelial sheets form tight barriers. Modulators of the cytoskeleton contribute to barrier stability and act as rheostats of vascular permeability. In this study, we sought to identify cytoskeletal regulators that underlie barrier diversity across vessels. To achieve this, we correlated functional and structural barrier features to gene expression of endothelial cells (ECs) derived from different vascular beds. Within a subset of identified candidates, we found that the guanosine nucleotide exchange factor Vav3 was exclusively expressed by microvascular ECs and was closely associated with a high-resistance barrier phenotype. Ectopic expression of Vav3 in large artery and brain ECs significantly enhanced barrier resistance and cortical rearrangement of the actin cytoskeleton. Mechanistically, we found that the barrier effect of Vav3 is dependent on its Dbl homology domain and downstream activation of Rap1. Importantly, inactivation of Vav3 in vivo resulted in increased vascular leakage, highlighting its function as a key regulator of barrier stability.

Indexed as

AnimalsCytoskeletonEndothelial CellsHumansMice, Inbred C57BLMicrovesselsProto-Oncogene Proteins c-vavProto-Oncogene Proteins c-vavVAV3 protein, humanVav3 protein, mouse

Identifiers

PMID29858212
PMCPMC6080943
OpenAlexW2805138100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.